A novel FLNA variant in a fetus with skeletal dysplasia
Otopalatodigital spectrum disorder (OPDSD) is characterized by variable phenotypes, including skeletal dysplasia, and is caused by pathogenic variants in filamin A-encoding FLNA.
Kyoko Oshina +7 more
doaj +2 more sources
Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia [PDF]
Background Recognition and appropriate management of the craniofacial manifestations of patients with skeletal dysplasia are challenging, due to the rarity of these conditions, and dearth of literature to support evidence-based clinical decision making ...
Ravi Savarirayan +14 more
doaj +2 more sources
The Bone Dysplasia Ontology: integrating genotype and phenotype information in the skeletal dysplasia domain [PDF]
Background Skeletal dysplasias are a rare and heterogeneous group of genetic disorders affecting skeletal development. Patients with skeletal dysplasias suffer from many complex medical issues including degenerative joint disease and neurological ...
Groza Tudor, Hunter Jane, Zankl Andreas
doaj +2 more sources
Paleopathological Study of Dwarfism-Related Skeletal Dysplasia in a Late Joseon Dynasty (South Korean) Population. [PDF]
Skeletal dysplasias related to genetic etiologies have rarely been reported for past populations. This report presents the skeletal characteristics of an individual with dwarfism-related skeletal dysplasia from South Korea. To assess abnormal deformities,
Eun Jin Woo +3 more
doaj +4 more sources
Thanatophoric Skeletal Dysplasia: A Case Report
Thanatophoric skeletal dysplasia is the most lethal, rare, sporadic birth defect due to de novo mutation in the fibroblast growth factor receptor-3. Clinically this is characterized by shortening of the limbs (micromelia), small conical thorax, flat ...
Firoz Anjum +2 more
doaj +2 more sources
SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects [PDF]
The majority of skeletal dysplasia are caused by pathogenic variants in genes required for glycosaminoglycan (GAG) metabolism. Here, Dubail et al. identify genetic variants in the solute carrier family protein SLC10A7 in families with skeletal dysplasia ...
Johanne Dubail +23 more
doaj +2 more sources
Oxandrolone therapy in skeletal dysplasia
Three patients with short stature and different forms of skeletal dysplasia were treated with oxandrolone, 1.25 mg/day. All patients had a normal growth hormone response (10 ng/ml) to the insulin-induced hypoglycemia test (ITT).
A Büyükgebiz, I Kovanlikaya
core +4 more sources
Heterozygous NPR2 Mutation in Two Family Members with Short Stature and Skeletal Dysplasia
Endochondral ossification at the level of the growth plate, an essential process involved in longitudinal growth, is regulated by hormonal and local factors including C-type natriuretic peptide and its receptor, natriuretic peptide receptor B.
Marianne Jacob +3 more
doaj +2 more sources
The skeletal dysplasias (osteochondrodysplasias) are a heterogeneous group of more than 350 disorders frequently associated with orthopedic complications and varying degrees of dwarfism or short stature. These disorders are diagnosed based on radiographic, clinical, and molecular criteria.
Deborah, Krakow, David L, Rimoin
openaire +2 more sources
Phenotyping CHST3 skeletal dysplasia from freezer-induced urine sediments
Skeletal dysplasias are a group of rare genetic disorders that affect growth and development of the skeleton, leading to physical deformities and other medical problems.
Packer, Nicolle H +5 more
core +1 more source

